BIOMAT Database Logo BIOMAT Database Logo

Hypertension in autosomal dominant polycystic kidney disease. 1995

P S Parfrey, and B J Barrett
Division of Nephrology, Health Sciences Centre, Memorial University, St John's, Newfoundland, Canada.

Hypertension occurs frequently in autosomal dominant polycystic kidney disease. Increased activity of the renin-angiotensin system contributes to the development and maintenance of hypertension before the development of renal failure. Angiotensin-converting enzyme inhibitors are indicated for treatment of hypertension before the development of renal failure, but in severe renal failure these agents may cause further deterioration in renal function. Treatment of hypertension may not retard the progression of renal failure but is necessary for the prevention of cardiovascular disease.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D016891 Polycystic Kidney, Autosomal Dominant Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function. Autosomal Dominant Polycystic Kidney,Kidney, Polycystic, Autosomal Dominant,ADPKD,Adult Polycystic Kidney Disease,Adult Polycystic Kidney Disease Type 1,Adult Polycystic Kidney Disease Type 2,Polycystic Kidney Disease 2,Polycystic Kidney Disease, Adult,Polycystic Kidney Disease, Adult Type 2,Polycystic Kidney Disease, Adult, Type II,Polycystic Kidney Disease, Autosomal Dominant,Polycystic Kidney Disease, Type 2,Polycystic Kidney, Type 1 Autosomal Dominant Disease,Polycystic Kidney, Type 2 Autosomal Dominant Disease
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

P S Parfrey, and B J Barrett
Hypertension in autosomal dominant polycystic kidney disease.
January 1999, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
P S Parfrey, and B J Barrett
Hypertension in autosomal dominant polycystic kidney disease.
November 1988, Kidney international,
P S Parfrey, and B J Barrett
Hypertension in autosomal dominant polycystic kidney disease.
March 2010, Advances in chronic kidney disease,
P S Parfrey, and B J Barrett
Hypertension in autosomal dominant polycystic kidney disease.
October 1997, Kidney international. Supplement,
P S Parfrey, and B J Barrett
Hypertension and autosomal dominant polycystic kidney disease.
June 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation,
P S Parfrey, and B J Barrett
Hypertension in autosomal-dominant polycystic kidney disease (ADPKD).
October 2013, Clinical kidney journal,
P S Parfrey, and B J Barrett
Proteinuria and hypertension in autosomal dominant polycystic kidney disease.
January 1996, Nephron,
P S Parfrey, and B J Barrett
Pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
November 1991, Seminars in nephrology,
P S Parfrey, and B J Barrett
Autosomal-dominant polycystic kidney disease and hypertension: a review.
January 1992, Contributions to nephrology,
P S Parfrey, and B J Barrett
Autosomal dominant polycystic kidney disease.
September 2014, American family physician,
Copied contents to your clipboard!